Publications

Browse recent peer reviewed articles reporting the results of Gilead-sponsored Clinical Trials. The list of publications below is limited to products that have been approved for use and may contain information about doses, delivery devices, uses, formulations and populations different from product labeling. Review articles are excluded. Clinical decisions should be based on the full safety and efficacy information contained in the product's Full Prescribing Information in the provide link next to the product name.

If you have questions about a Gilead-sponsored clinical trial not listed below or would like to request an electronic copy of one of the journal publications on this page, please contact Gilead Medical Information below for further assistance.

Select a product to view publications

Atripla®

efavirenz 600 mg/emtricitabine 200 mg/tenofovlr disoproxil fumarate 300 mg

Truvada®

emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

Biktarvy®

bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg

Cayston®

aztreonam for inhalation solution 75 mg/vial

Complera®

emtricitabine 200 mg/rilpivirine 25 mg/tenofovir disoproxil fumarate 300 mg

Genvoya®

elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200mg/tenofovir alafenamide 10 mg

Odefsey®

emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg

Stribild®

elvitegravlr 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

Vosevi®

sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg tablets
Looking for more publication details?
Contact Gilead Medical Resource Center
1-866-MEDI-GSI (1-866-633-4474) | Monday – Friday, 5am – 6pm PT